Nitrofurantoin Tillomed Laboratories

Nitrofurantoin, the active ingredient in Nitrofurantoin Tillomed Laboratories, is a nitrofuran antibiotic presented as an oral tablet for oral use. It treats uncomplicated urinary tract infections and cystitis in adult patients. GNH USA supplies Nitrofurantoin Tillomed Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrofurantoin is used to treat bacterial infections of the lower urinary tract. - Uncomplicated urinary tract infection: eliminates the causative bacteria, relieving symptoms and preventing progression. - Cystitis: reduces bacterial load in the bladder, leading to clinical improvement. - Acute uncomplicated cystitis: provides rapid bacterial eradication and symptom relief.

Nitrofurantoin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional episodes after dosing. - Loss of appetite: reduced desire to eat. - Diarrhea: loose stools, usually transient. - Headache: mild cranial discomfort. - Metallic taste: persistent metallic sensation in the mouth.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute respiratory distress. - Liver injury: hepatitis or cholestasis. - Severe allergic reactions: rash, Stevens‑Johnson syndrome, or anaphylaxis. - Hemolytic anemia in G6PD deficiency: rapid destruction of red blood cells. - Peripheral neuropathy: tingling or numbness in extremities. - Blood dyscrasias: agranulocytosis, leukopenia, or thrombocytopenia.

Before prescribing Nitrofurantoin, clinicians should consider several safety factors. - Renal function: assess creatinine clearance; avoid if severely impaired. - Pregnancy: avoid unless benefits outweigh potential risks. - Breastfeeding: use with caution; monitor infant for adverse effects. - G6PD deficiency: contraindicated due to risk of hemolysis. - Drug interactions: review concomitant medications for potential effects on absorption or toxicity. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nitrofurantoin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce nitrofurantoin absorption. - Probenecid: may increase nitrofurantoin plasma concentrations, raising toxicity risk. - Trimethoprim‑sulfamethoxazole: additive renal toxicity and reduced antibacterial effect.

Moderate Interactions (Monitor Closely): - Warfarin: nitrofurantoin may enhance anticoagulant effect, requiring INR monitoring. - Ciprofloxacin: may interfere with nitrofurantoin’s antibacterial activity. - Diuretics: altered renal clearance may affect drug levels.